|
[1] LIWINSKI T,SCHRAMM C. Autoimmune hepatitis-update on clinical management in 2017[J]. Clin Res Hepatol Gastroenterol,2017,41(6):617-625.
|
|
[2] WALDENSTROM J. Liver,blood proteins and food proteins[J].Dtsch Z Verdau Stoffwechselkr,1952,12(Spec No):113-121.
|
|
[3] WEBB GJ,HIRSCHFIELD GM. Using GWAS to identify genetic predisposition in hepatic autoimmunity[J]. J Autoimmun,2016,66:25-39.
|
|
[4] de BOER YS,van GERVEN NM,ZWIERS A,et al. Genomewide association study identifies variants associated with autoimmune hepatitis type 1[J]. Gastroenterology,2014,147(2):443-452.
|
|
[5] van GERVEN NM,de BOER YS,ZWIERS A,et al. HLADRB1*03∶01 and HLA-DRB1*04∶01 modify the presentation and outcome in autoimmune hepatitis type-1[J]. Genes Immun,2015,16(4):247-252.
|
|
[6] BITTENCOURT PL,GOLDBERG AC,CANCADO EL,et al. Genetic heterogeneity in susceptibility to autoimmune hepatitis types1 and 2[J]. Am J Gastroenterol,1999,94(7):1906-1913.
|
|
[7] OKA S,FURUKAWA H,YASUNAMI M,et al. HLA-DRB1and DQB1 alleles in Japanese type 1 autoimmune hepatitis:The predisposing role of the DR4/DR8 heterozygous genotype[J]. PLo S One,2017,12(10):e187325.
|
|
[8] MA Y,BOGDANOS DP,HUSSAIN MJ,et al. Polyclonal Tcell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2[J]. Gastroenterology,2006,130(3):868-882.
|
|
[9] OKA S,HIGUCHI T,FURUKAWA H,et al. Association of a single nucleotide polymorphism in TNIP1 with type-1 autoimmune hepatitis in the Japanese population[J]. J Hum Genet,2018,63(6):739-744.
|
|
[10] ESKANDARI-NASAB E,TAHMASEBI A,HASHEMI M. Meta-analysis:The relationship between CTLA-4+49 A/G polymorphism and primary biliary cirrhosis and type I autoimmune hepatitis[J]. Immunol Invest,2015,44(4):331-348.
|
|
[11] CHAOUALI M,AZAIEZ MB,TEZEGHDENTI A,et al. Association of TNF-alpha-308 polymorphism with susceptibility to autoimmune hepatitis in Tunisians[J]. Biochem Genet,2018,56(6):650-662.
|
|
[12] XU E,CAO H,LIN L,et al. rs10499194 polymorphism in the tumor necrosis factor-alpha inducible protein 3(TNFAIP3)gene is associated with type-1 autoimmune hepatitis risk in Chinese Han population[J]. PLo S One,2017,12(4):e176471.
|
|
[13] HIGUCHI T,OKA S,FURUKAWA H,et al. Association of a single nucleotide polymorphism upstream of ICOS with Japanese autoimmune hepatitis type 1[J]. J Hum Genet,2017,62(4):481-484.
|
|
[14] MIGITA K,JIUCHI Y,FURUKAWA H,et al. Lack of association between the CARD10 rs6000782 polymorphism and type 1autoimmune hepatitis in a Japanese population[J]. BMC Res Notes,2015,8:777.
|
|
[15] ASSIS DN,TAKAHASHI H,LENG L,et al. A macrophage migration inhibitory factor polymorphism is associated with autoimmune hepatitis severity in US and Japanese patients[J].Dig Dis Sci,2016,61(12):3506-3512.
|
|
[16] CHAOUALI M,FERNANDES V,GHAZOUANI E,et al. Association of STAT4, TGFbeta1, SH2B3 and PTPN22 polymorphisms with autoimmune hepatitis[J]. Exp Mol Pathol,2018,105(3):279-284.
|
|
[17] WEBB G,CHEN YY,LI KK,et al. Single-gene association between GATA-2 and autoimmune hepatitis:A novel genetic insight highlighting immunologic pathways to disease[J]. J Hepatol,2016,64(5):1190-1193.
|
|
[18] YOUSEFI A,MAHMOUDI E,ZARE BA,et al. IL4 gene polymorphisms in Iranian patients with autoimmune hepatitis[J].Expert Rev Gastroenterol Hepatol,2016,10(5):659-663.
|
|
[19] YOUSEFI A,ZARE BA,SHAFIOYOUN A,et al. Association of IL-10 and TGF-beta cytokine gene polymorphisms with autoimmune hepatitis[J]. Clin Res Hepatol Gastroenterol,2019,43(1):45-50.
|
|
[20] FLOREANI A,RESTREPO-JIMENEZ P,SECCHI MF,et al.Etiopathogenesis of autoimmune hepatitis[J]. J Autoimmun,2018,95:133-143.
|
|
[21] EDER M,STRASSL R,BEINHARDT S,et al. high seroprevalence of anti-hepatitis E antibodies in Austrian patients with autoimmune hepatitis[J]. Liver Int,2019,39(4):640-645.
|
|
[22] TERZIROLI BB,RIPELLINO P,GOBBI C,et al. Autoimmune liver disease serology in acute hepatitis E virus infection[J]. J Autoimmun,2018,94:1-6.
|
|
[23] PAIARDINI A,PASCARELLA S. Structural mimicry between SLA/LP and Rickettsia surface antigens as a driver of autoimmune hepatitis:Insights from an in silico study[J]. Theor Biol Med Model,2013,10:25.
|
|
[24] CHRISTEN U,HINTERMANN E. Pathogen infection as a possible cause for autoimmune hepatitis[J]. Int Rev Immunol,2014,33(4):296-313.
|
|
[25] MA Y,GAKEN J,MCFARLANE BM,et al. Alcohol dehydrogenase:A target of humoral autoimmune response in liver disease[J]. Gastroenterology,1997,112(2):483-492.
|
|
[26] NGU JH,GEARRY RB,FRAMPTON CM,et al. Autoimmune hepatitis:The role of environmental risk factors:A population-based study[J]. Hepatol Int,2013,7(3):869-875.
|
|
[27] ANAYA JM,RESTREPO-JIMENEZ P,RAMIREZ-SANTANA C. The autoimmune ecology:An update[J]. Curr Opin Rheumatol,2018,30(4):350-360.
|
|
[28] CZAJA AJ,MONTANO-LOZA AJ. Evolving role of vitamin D in immune-mediated disease and its implications in autoimmune hepatitis[J]. Dig Dis Sci,2019,64(2):324-344.
|
|
[29] LUONG KV,NGUYEN LT. The role of vitamin D in autoimmune hepatitis[J]. J Clin Med Res,2013,5(6):407-415.
|
|
[30] EBADI M,BHANJI RA,MAZURAK VC,et al. Severe vitamin D deficiency is a prognostic biomarker in autoimmune hepatitis[J]. Aliment Pharmacol Ther,2019,49(2):173-182.
|
|
[31] CAI W,RAN Y,LI Y,et al. Intestinal microbiome and permeability in patients with autoimmune hepatitis[J]. Best Pract Res Clin Gastroenterol,2017,31(6):669-673.
|
|
[32] NGO ST,STEYN FJ,MCCOMBE PA. Gender differences in autoimmune disease[J]. Front Neuroendocrinol,2014,35(3):347-369.
|
|
[33] SCHWINGE D,SCHRAMM C. Sex-related factors in autoimmune liver diseases[J]. Semin Immunopathol,2019,41(2):165-175.
|
|
[34] CASTIELLA A,ZAPATA E,LUCENA MI,et al. Drug-induced autoimmune liver disease:A diagnostic dilemma of an increasingly reported disease[J]. World J Hepatol,2014,6(4):160-168.
|
|
[35] DELEMOS AS,FOUREAU DM,JACOBS C,et al. Drug-induced liver injury with autoimmune features[J]. Semin Liver Dis,2014,34(2):194-204.
|
|
[36] GAO XQ,ZHAO YX,REN Q,et al. Research advances in drug-induced autoimmune hepatitis[J]. J Clin Hepatol,2017,33(11):2222-2225.(in Chinese)高晓琴,赵永勋,任茜,等.药物诱导的自身免疫性肝炎的研究进展[J].临床肝胆病杂志,2017,33(11):2222-2225.
|
|
[37] CZAJA AJ. Transitioning from idiopathic to explainable autoimmune hepatitis[J]. Dig Dis Sci,2015,60(10):2881-2900.
|
|
[38] HISAMOCHI A,KAGE M,IDE T,et al. An analysis of druginduced liver injury,which showed histological findings similar to autoimmune hepatitis[J]. J Gastroenterol,2016,51(6):597-607.
|
|
[39] de BOER YS,KOSINSKI AS,URBAN TJ,et al. Features of autoimmune hepatitis in patients with drug-induced liver injury[J]. Clin Gastroenterol Hepatol,2017,15(1):103-112.
|
|
[40] AVERBUKH LD,WU GY. Role of biologics in the development of autoimmune hepatitis:A review[J]. J Clin Transl Hepatol,2018,6(4):402-409.
|
|
[41] NISHIDA N,KUDO M. Liver damage related to immune checkpoint inhibitors[J]. Hepatol Int,2019,13(3):248-252.
|
|
[42] LIU YJ,WANG GC. Relationship of MCP-1,chronic hepatic disease and its complications[J/CD]. Chin J Liver Dis:Electr Version,2017,9(4):31-37.(in Chinese)刘英娇,王拱辰.单核细胞趋化蛋白-1与慢性肝病及并其发症的相关性[J/CD].中国肝脏病杂志:电子版,2017,9(4):31-37.
|
|
[43] WANG J,IOAN-FACSINAY A,van der VOORT EI,et al. Transient expression of FOXP3 in human activated nonregulatory CD4+T cells[J]. Eur J Immunol,2007,37(1):129-138.
|
|
[44] LIU Y,YAN W,YUAN W,et al. Treg/Th17 imbalance is associated with poor autoimmune hepatitis prognosis[J]. Clin Immunol,2019,198:79-88.
|
|
[45] PAN J,PAN WT,WU LH. Expression and significance of Th22cells and its functional factor interleukin-22 in mice with autoimmune hepatitis[J]. J Clin Hepatol,2018,34(8):1745-1749.(in Chinese)潘景,潘文婷,吴丽慧.辅助性T淋巴细胞22及其效应因子IL-22在自身免疫性肝炎小鼠模型中的表达及意义[J].临床肝胆病杂志,2018,34(8):1745-1749.
|
|
[46] ABE K,TAKAHASHI A,FUJITA M,et al. Interleukin-33/ST2-mediated inflammation plays a critical role in the pathogenesis and severity of type I autoimmune hepatitis[J]. Hepatol Commun,2019,3(5):670-684.
|
|
[47] KERKAR N,YANNI G.‘De novo’and ‘recurrent’autoimmune hepatitis after liver transplantation:A comprehensive review[J]. J Autoimmun,2016,66:17-24.
|
|
[48] VUKOTIC R,VITALE G,D'ERRICO-GRIGIONI A,et al. De novo autoimmune hepatitis in liver transplant:State-of-the-art review[J]. World J Gastroenterol,2016,22(10):2906-2914.
|
|
[49] ENNAIFER R,AVADI H,ROMDHANE H,et al. De novo autoimmune hepatitis following liver transplantation for primary biliary cirrhosis:An unusual cause of late grafts dysfunction[J].Pan Afr Med J,2015,21:2.
|
|
[50] CZAJA AJ. Factoring the intestinal microbiome into the pathogenesis of autoimmune hepatitis[J]. World J Gastroenterol,2016,22(42):9257-9278.
|
DownLoad: